KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Payables (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Payables readings, the most recent being $3.3 billion for Q1 2026.

  • On a quarterly basis, Payables rose 9.68% to $3.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.3 billion, a 9.68% increase, with the full-year FY2025 number at $3.6 billion, up 17.64% from a year prior.
  • Payables hit $3.3 billion in Q1 2026 for Thermo Fisher Scientific, down from $3.6 billion in the prior quarter.
  • In the past five years, Payables ranged from a high of $3.6 billion in Q4 2025 to a low of $2.4 billion in Q3 2023.
  • Median Payables over the past 5 years was $2.8 billion (2023), compared with a mean of $2.9 billion.
  • Biggest five-year swings in Payables: rose 24.28% in 2022 and later decreased 15.05% in 2023.
  • Thermo Fisher Scientific's Payables stood at $3.4 billion in 2022, then decreased by 15.05% to $2.9 billion in 2023, then increased by 7.21% to $3.1 billion in 2024, then increased by 17.64% to $3.6 billion in 2025, then decreased by 7.68% to $3.3 billion in 2026.
  • The last three reported values for Payables were $3.3 billion (Q1 2026), $3.6 billion (Q4 2025), and $3.1 billion (Q3 2025) per Business Quant data.